Form 4: Korro Bio Investor Mohamad Makhzoumi Acquires Additional Shares

Mohamad Makhzoumi, a director indirectly associated with NEA 17, acquired 17,857 shares of Korro Bio, Inc. common stock at $56 per share on April 22, 2024.

Summary

• On April 22, 2024, Mohamad Makhzoumi, indirectly through NEA 17, purchased 17,857 shares of Korro Bio, Inc. common stock at a price of $56 per share.
• Following this transaction, the total number of shares beneficially owned indirectly by the reporting person is 1,090,793.
• The shares were acquired pursuant to a Subscription Agreement dated April 17, 2024.
• Makhzoumi disclaims beneficial ownership of the securities held by NEA 17 except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard transaction disclosure. The purchase of shares by an insider is generally viewed as a positive sign, but without additional context, it's difficult to gauge the overall impact.

Positives

• The purchase of additional shares by a director could be seen as a positive signal about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell the company's securities. This filing indicates changes in beneficial ownership and provides transparency to the market.

Stakeholder Impact

• The purchase of shares by a significant shareholder could increase investor confidence.

Key Dates